Contract manufacturing

The biopharmaceutical contract biomanufacturing market is projected to be worth USD 32.4 billion by 2030, – Roots Analysis

Health & Safety / /

Roots Analysis has announced the addition of the “Biopharmaceutical Contract Biomanufacturing Market, (4th Edition), 2020-2030” report to its list of offerings. Given the rising popularity of biologics and the 8,000+ such product candidates under clinical investigation, the opportunity for contract manufacturing service providers engaged in this domain, is high and anticipated to persist in the […]

The biopharmaceutical contract biomanufacturing market is projected to be worth USD 32.4 billion by 2030, – Roots Analysis Read More »

China Biopharmaceutical Contract Manufacturing Market – Gaining Traction in the Pharmaceutical Industry

Health & Fitness / /

The “China Biopharmaceutical Contract Manufacturing Market, 2020-2030” report features an extensive study of the current market landscape and future opportunities associated with the contract manufacturing of biopharmaceuticals in China. The study also features a detailed analysis of key drivers and trends related to this evolving domain.   The current biopharmaceuticals market is characterized by high

China Biopharmaceutical Contract Manufacturing Market – Gaining Traction in the Pharmaceutical Industry Read More »

The contract manufacturing market for Pharmaceuticals in China – Roots Analysis

Health & Safety / /

Owing to reasons, such as a booming economy and availability of skilled labor, outsourcing to Asian CMOs, primarily in China, is considered an attractive business model to pharmaceutical developers / sponsors, across the world   Roots Analysis is pleased to announce the publication of its recent study, titled, “China Pharmaceutical Contract Manufacturing Services Market, 2020-2030.”

The contract manufacturing market for Pharmaceuticals in China – Roots Analysis Read More »